Cambridge-based AnthroTek Closes £950K Seed Round
At a glance
This article covers a seed round on 2025-06-25 for AnthroTek, a Cambridge-based synthetic anatomy startup founded by Nazmus Tareque and Dr. Raoul Peltier. The company raised £950K.
What does AnthroTek do?
AnthroTek makes synthetic anatomy components combining silicone composites and AI-driven 3D models that replicate human tissue properties. They are used to train clinicians, support hands-on medical practice, and produce lifelike parts for film.
Why is AnthroTek useful?
Problem
Medical trainers, robotics developers and filmmakers face a lack of realistic, ethical human tissue models for training, testing and prosthetics.
Solution
AnthroTek helps by using silicone composites and AI-driven 3D models to make lifelike, cadaver-free tissues and sensor-embedded skins.
How much did AnthroTek raise?
AnthroTek raised £950K in a seed round.
Who invested in AnthroTek?
Key investors and strategic backers in the round included the following.
- Nazmus Tareque: an angel investor bringing expertise in law and commercialisation, and a co-founder of the company.
- Dr. Raoul Peltier: an angel investor with a background in materials science and nanotechnology, noted for his research, publications and patent work.
- Genie AI: a strategic backer and legal-automation partner known for its contract automation platform, focused on lowering legal costs and speeding up deal processes.
If you're researching potential backers in this space:
- Explore our list of AI venture capital firms in the UK
- Browse our directory of AI angel investors in the UK
Who founded AnthroTek?
The founders of AnthroTek are Nazmus Tareque, co-founder and Chief Commercial Officer, and Dr. Raoul Peltier, a materials scientist.
Where is AnthroTek based?
AnthroTek is based in Cambridge, UK.
What sector is AnthroTek in?
AnthroTek operates in the synthetic anatomy sector. The sector makes realistic artificial human tissues and models for medical training, robotics and film.
Key trends and challenges in Synthetic anatomy:
Multidisciplinary convergence
Convergence of materials science, AI and 3D modelling is producing more lifelike tissue simulators for training, robotics and film.
Regulatory and clinical validation
Regulatory validation for medical simulation products remains slow, requiring clinical studies and formal acceptance by hospitals.
Manufacturing scale and cost control
Scaling manufacturing while keeping costs and quality consistent is hard, especially for sensor-embedded skins and specialised silicones.
For a deeper look at innovation in this space, see the latest funded AI startups in the UK
Click here for a full list of 7,233+ startup investors in the UK